Search

Quality of Life and Symptoms

The goals of the SWG are:

To promote the evaluation of patient-reported outcomes (PROs) in hematology in daily clinical practice and in clinical trials.

Read more

ABT-199: Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in high-risk CLL.

Chronic Lymphocytic Leukaemia (CLL) is the most common leukemia in adults in the Western world and is diagnosed in approximately 5 persons per 100,000 population per year.

Read more

A new form of inherited thrombocytopenia (ETV6-related thrombocytopenia, ETV6-RT): NEVER JUDGE A BOOK BY ITS COVER!

A new form of inherited thrombocytopenia (ETV6-related thrombocytopenia, ETV6-RT): NEVER JUDGE A BOOK BY ITS COVER!

We recently discovered a new form of an inherited deficiency of platelets (inherited thrombocytopenia-IT), which is caused by mutations in the ETV6-gene.

Read more

European Board for Accreditation in Hematology

Current committee members
Harry Schouten, The Netherlands (Chair)
Anna Porwit, Sweden (Vice-Chair)
Gunnar Birgegård, Sweden, General skills and ethics
Peter van den Burg, The Netherlands, Transfusion Medicine (ISBT)
Eleni Gavriilaki, Greece (Representative clinical hematology)
Michelle Kenyon, United Kingdom, Specialized Hematology Professional (EBMT Nurses Group)
Fionnuala Ní Áinle,…

Read more